Nicosan

Nicosan is a herbal supplement that was developed and marketed by Xechem International for the treatment of Sickle Cell Disease. It was originally developed in Nigeria and was approved for use in that country in 2006. However, due to financial difficulties, Xechem was unable to continue production and the supplement is no longer available.

History

Nicosan was developed by Xechem International, a pharmaceutical company based in the United States. The company was granted a patent for the supplement in 2006 and it was approved for use in Nigeria the same year. However, due to financial difficulties, Xechem was unable to continue production and the supplement is no longer available.

Composition

Nicosan is a herbal supplement that is composed of four main ingredients: Piper guineense, Pterocarpus osun, Eugenia caryophyllus, and Sorghum bicolor. These ingredients are all plants that are native to Africa and have been used in traditional medicine for centuries.

Use in Sickle Cell Disease

Nicosan was marketed as a treatment for Sickle Cell Disease, a genetic disorder that affects the red blood cells. The supplement was said to help reduce the frequency and severity of sickle cell crises, which are episodes of pain that occur when the misshapen red blood cells block blood vessels.

Controversy and Discontinuation

Despite its approval in Nigeria, Nicosan faced controversy due to the lack of rigorous clinical trials to support its efficacy. In addition, Xechem faced financial difficulties and was unable to continue production of the supplement. As a result, Nicosan is no longer available.

See Also

• Sickle Cell Disease
• Herbal Medicine
• Xechem International

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia